Todd E. Shegog
Independent DirectorMr. Todd E. Shegog is an Independent Director of Mentari Therapeutics, Inc. from November 9, 2026. Mr. Shegog has been Independent Director of Cogent Biosciences, Inc. since February 22, 2021. He has financial, operations, corporate strategy and compliance expertise in the biotechnology and pharmaceutical industries. He served as Senior Vice President and Chief Financial Officer at Forma Therapeutics Holdings, Inc. and Forma Therapeutics, Inc. since September 2019. He joined Forma Therapeutics, Inc. in September 2019. Mr. Shegog served as Chief Financial Officer at Synlogic, Inc since September 12, 2016 until September 18, 2019. He served as the Chief Financial Officer and Senior Vice President at FORUM Pharmaceuticals Inc. since April 22, 2014 to August 2016, where he was responsible for finance, operations and information systems during their pursuit of innovative therapies for schizophrenia and Alzheimer’s disease. He was Senior Vice President of Finance and Chief Financial Officer of Millennium Pharmaceuticals, Inc. now Takeda Oncology from 2008 to March 2014 and served as its Vice President of Finance and Treasurer. He joined Millennium in 1998 and draws finance experience in the biotechnology industry. From 1998 to 2014, Mr. Shegog held key leadership roles supporting the early evolution of Millennium and its transformation from a genomics company to a fully-integrated drug developer, the approval and launch of its flagship oncology product, VELCADE(R). Previously, he spent several years at Genetics Institute (now Wyeth) in a variety of financial positions supporting the Research and Development organizations as well a member of the Commercial Operations team supporting the launch of BeneFIX®. Mr. Shegog holds a B.S. in electrical engineering from Lafayette College and an M.B.A. in finance from the Tepper School of Management at Carnegie Mellon University.
Positions
- Company NameCogent Biosciences, Inc.Stock CodeCOGTPositionIndependent DirectorColleagues
- ARAndrew R. RobbinsPresident, CEO & Director
- PEPeter Evan HarwinIndependent Chairman of the Board
- JLJohn L. GreenCFO & Principal Accounting Officer
- JEJohn Edward RobinsonChief Scientific Officer
- JSJessica SachsChief Medical Officer
- CPCole PinnowChief Commercial Officer
- KJKaren Jean FerranteIndependent Director
- AMArlene M. MorrisIndependent Director
- TETodd E. ShegogIndependent Director
- Company NameMentari Therapeutics, Inc.Stock CodeMTRIPositionIndependent DirectorColleagues
- GJGregory J. DivisCEO & Director
- JBJulianne BrunoIndependent Chairperson of the Board
- BRBrett R. HagenCAO & Senior VP of Finance
- KNKelly NeelonChief Technical Officer
- JGJerad G. SeurerGeneral Counsel & Corporate Secretary
- AKAmanda KunevichChief People Officer
- LSLaura SandlerIndependent Director
- MPMichelle PerniceIndependent Director
